Skip to content

NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE      HIV • HCV • STIs • SUBSTANCE USE • LGBT HEALTH

HIVQUAL • CEI TRAINING

  • JOIN OUR MAIL LIST
  • ABOUT US
  • POCKET GUIDES & SLIDES
  • HOME

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • HIV Testing and Acute HIV
  • HIV Treatment
  • PEP and PrEP
  • Hepatitis Care
  • Primary and Specialty HIV Care
  • HPV-Related Cancer Prevention
  • Sexual Health
  • Perinatal HIV Prevention
  • Substance Use

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations (9/22/21)

https://content.govdelivery.com/accounts/USFDA/bulletins/2f40e32

Post navigation

Previous Previous post: PrEP Aware Week — Save the Dates: October 25 to 31 (9/17/20)
Next Next post: NYCDOHMH: Booster Dose for Pfizer-BioNTech COVID-19 Vaccine (9/28/21)

This website is managed by the Clinical Guidelines Program in the JHU School of Medicine, Division of Infectious Diseases, on behalf of the NYSDOH AIDS Institute. Carnegie 3, Rm 386, 600 North Wolfe Street, Baltimore, MD 21287

Quick Links: About | Guideline Development | About the Site | New York State Department of Health | AIDS Institute

Contact us: aiguidelines@jhmi.edu

Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2024. All Rights Reserved.